共 242 条
[1]
Go AS(2001)Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2370-2375
[2]
Hylek EM(2013)Atrial fibrillation prevalence revisited J Intern Med 274 461-468
[3]
Phillips KA(1987)Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study Arch Intern Med 147 1561-1564
[4]
Chang Y(2011)Guidelines on oral anticoagulation with warfarin: fourth edition Br J Haematol 154 311-324
[5]
Henault LE(2007)Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices Ann Med 39 371-391
[6]
Selby JV(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-e76
[7]
Friberg L(2012)Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 e531S-e575S
[8]
Bergfeldt L(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 955-962
[9]
Wolf PA(2012)Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review Ann Intern Med 157 796-807
[10]
Abbott RD(2012)Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation Circ Cardiovasc Qual Outcomes. 5 480-486